Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

References

• VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
   PubMed Web of Science ®Google Scholar
• WilkeSJonesPWMüllerovaHOne-year change in health status and subsequent outcomes in COPDThorax201570542042525782757
   PubMed Web of Science ®Google Scholar
• MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• BeehKMGlaabTStowasserSCharacterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialRespir Res20131411624168767
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• KimVCrinerGJChronic bronchitis and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187322823723204254
   PubMed Web of Science ®Google Scholar
• De SoyzaACalverleyPMLarge trials, new knowledge: the changing face of COPD managementEur Respir J20154561692170325792640
   PubMed Web of Science ®Google Scholar
• VestboJAgustiAWoutersEFShould we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study teamAm J Respir Crit Care Med201418991022103024552242
   PubMed Web of Science ®Google Scholar
• FarneHACatesCJLong-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201510CD00898926490945
   PubMed Web of Science ®Google Scholar
• DecramerMLChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma2016 GINA Report: Global Strategy for Asthma Management and PreventionBethesda (MD)GINA2016
   Google Scholar
• WiseRAAnzuetoACalverleyPThe Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleRespir Res2013144023547660
   PubMed Web of Science ®Google Scholar
• WiseRAAnzuetoACottonDTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med2013369161491150123992515
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSRodriguez-RoisinRThe 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD): why and what?Clin Respir J20126420821422906068
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseBethesda (MD)GOLD2016
   Google Scholar
• BuschRHanMKBowlerRPRisk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohortBMC Pulm Med2016162826861867
   PubMed Web of Science ®Google Scholar
• BurgelPRChronic cough and sputum production: a clinical COPD phenotype?Eur Respir J20124014622753831
   PubMed Web of Science ®Google Scholar
• KimVSternbergALWashkoGSevere chronic bronchitis in advanced emphysema increases mortality and hospitalizationsCOPD201310666767823978192
   PubMedGoogle Scholar
• KimVCrapoJZhaoHComparison between an alternative and the classic definition of chronic bronchitis in COPDGeneAnn Am Thorac Soc201512333233925575351
   PubMed Web of Science ®Google Scholar
• CelliBVestboJJenkinsCRSex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease: the TORCH experienceAm J Respir Crit Care Med2011183331732220813884
   PubMed Web of Science ®Google Scholar
• KilicHKokturkNSariGCakirMDo females behave differently in COPD exacerbation?Int J Chron Obstruct Pulmon Dis20151082383025977604
   PubMed Web of Science ®Google Scholar
• DonaldsonGCMüllerovaHLocantoreNFactors associated with change in exacerbation frequency in COPDRespir Res2013147923899210
   PubMed Web of Science ®Google Scholar
• HanMKQuibreraPMCarrettaEEFrequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortLancet Respir Med20175861962628668356
   PubMed Web of Science ®Google Scholar
• CelliBRDecramerMAsijeeGMKupasKTashkinDPEffects of tiotropium on exacerbations in patients with COPD with low or high risk of exacerbations: a post-hoc analysis from the 4-year UPLIFT trialChronic Obstr Pulm Dis20152212213028848836
   PubMedGoogle Scholar
• VogelmeierCFAsijeeGMKupasKBeehKMTiotropium and salmeterol in COPD patients at risk of exacerbations: a post hoc analysis from POET-COPDAdv Ther201532653754726100349
   PubMed Web of Science ®Google Scholar
• WedzichaJARabeKFMartinezFJEfficacy of roflumilast in the COPD frequent exacerbator phenotypeChest201314351302131123117188
   PubMed Web of Science ®Google Scholar
• MüllerovaHShuklaAHawkinsAQuintJRisk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyBMJ Open2014412e006171
   PubMed Web of Science ®Google Scholar
• BatemanEDRabeKFCalverleyPMRoflumilast with long-acting β2-agonists for COPD: influence of exacerbation historyEur Respir J201138355356021737553
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• CelliBDecramerMKestenSMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20091801094895519729663
   PubMed Web of Science ®Google Scholar
• ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
   PubMed Web of Science ®Google Scholar
• MakeBJErikssonGCalverleyPMA score to predict short-term risk of COPD exacerbations (SCOPEX)Int J Chron Obstruct Pulmon Dis20151020120925670896
   PubMed Web of Science ®Google Scholar